Sree Rayalaseema Hi-Strength Hypo Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹417.56Overvalued by 13.19%vs CMP ₹481.00

P/E (8.0) × ROE (11.0%) × BV (₹588.00) × DY (0.62%)

₹587.08Undervalued by 22.05%vs CMP ₹481.00
MoS: +18.1% (Adequate)Confidence: 48/100 (Moderate)Models: 5 Under, 2 Fair, 2 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹410.8622%Over (-14.6%)
Graham NumberEarnings₹854.8116%Under (+77.7%)
Earnings PowerEarnings₹482.5511%Fair (+0.3%)
DCFCash Flow₹579.4313%Under (+20.5%)
Net Asset ValueAssets₹588.157%Under (+22.3%)
EV/EBITDAEnterprise₹467.619%Fair (-2.8%)
Earnings YieldEarnings₹552.307%Under (+14.8%)
ROCE CapitalReturns₹1,069.819%Under (+122.4%)
Revenue MultipleRevenue₹185.765%Over (-61.4%)
Consensus (9 models)₹587.08100%Undervalued
Key Drivers: Wide model spread (₹186–₹1,070) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: -1.6%

*Investments are subject to market risks

Analyst Summary

Sree Rayalaseema Hi-Strength Hypo Ltd operates in the Chemicals - Inorganic - Others segment, current market price is ₹481.00, market cap is 826 Cr.. At a glance, stock P/E is 8.02, ROE is 11.0 %, ROCE is 14.9 %, book value is 588, dividend yield is 0.62 %. The latest intrinsic value estimate is ₹587.08, which is about 22.1% above the current price, so the page currently reads as potentially undervalued rather than fully priced. On operating trend, latest reported sales are about ₹638 Cr versus the prior period change of -26.3%, while latest net profit is about ₹93 Cr with a prior-period change of 16.3%. The 52-week range shown on this page is 717/381, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisSree Rayalaseema Hi-Strength Hypo Ltd. is a Public Limited Listed company incorporated on 28/03/2005 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identifica…

This summary is generated from the stock page data available for Sree Rayalaseema Hi-Strength Hypo Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

64
Sree Rayalaseema Hi-Strength Hypo Ltd scores 64/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health76/100 · Strong
ROCE 14.9% GoodROE 11.0% AverageD/E 0.15 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money50/100 · Moderate
FII holding stable No changePromoter holding at 61.8% Stable
Earnings Quality65/100 · Strong
OPM expanding (12% → 14%) Improving
Quarterly Momentum58/100 · Moderate
Revenue (4Q): 3% YoY FlatProfit (4Q): +3% YoY Positive
Industry Rank55/100 · Moderate
P/E 8.0 vs industry 90.6 Cheaper than peersROCE 14.9% vs industry 14.0% Average3Y sales CAGR: -20% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 26, 2026, 12:13 am

Market Cap 826 Cr.
Current Price 481
Intrinsic Value₹587.08
High / Low 717/381
Stock P/E8.02
Book Value 588
Dividend Yield0.62 %
ROCE14.9 %
ROE11.0 %
Face Value 10.0
PEG Ratio-5.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Sree Rayalaseema Hi-Strength Hypo Ltd

Competitors

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
Sree Rayalaseema Hi-Strength Hypo Ltd 826 Cr. 481 717/3818.02 5880.62 %14.9 %11.0 % 10.0
A-1 Acid Ltd 551 Cr. 12.0 70.4/10.8223 1.060.31 %10.6 %7.82 % 1.00
Alufluoride Ltd 440 Cr. 562 580/37618.6 1440.53 %23.6 %20.8 % 10.0
Cochin Minerals & Rutile Ltd 221 Cr. 282 356/19715.0 2112.84 %23.3 %15.0 % 10.0
Fischer Medical Ventures Ltd 2,430 Cr. 37.1 125/32.061.4 5.550.01 %1.08 %0.70 % 1.00
Industry Average4,860.50 Cr408.5790.58156.250.48%13.95%10.65%6.18

All Competitor Stocks of Sree Rayalaseema Hi-Strength Hypo Ltd

Quarterly Result

MetricDec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales 301435261226215165169170138160180182141
Expenses 274371226199192138142140117143152155121
Operating Profit 26643526222727302118282720
OPM % 9%15%13%12%10%16%16%18%15%11%16%15%14%
Other Income 112012453913126716
Interest 0111120001000
Depreciation 5533331211111
Profit before tax 32793325232728363228323235
Tax % 26%9%26%27%29%23%26%29%27%19%28%24%30%
Net Profit 24712418172120262423232424
EPS in Rs 13.7241.4514.1710.789.6912.2211.9415.1213.7113.2313.6414.2014.16

Last Updated: March 3, 2026, 2:36 pm

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 25, 2026, 11:16 pm

MetricMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales 2953923623665467026899111,2671,650866638664
Expenses 2623513183175006045877811,1191,470755542570
Operating Profit 3341445046981021301491801119694
OPM % 11%10%12%14%8%14%15%14%12%11%13%15%14%
Other Income 992-2195471134133641
Interest 161411891610535422
Depreciation 151010251945505119191166
Profit before tax 1226261537424581137190109124127
Tax % 36%25%27%-27%1%52%17%25%25%19%26%25%
Net Profit 719191837203861103154809395
EPS in Rs 5.0613.1612.7211.8622.4511.9022.0935.3059.8889.9046.8553.9955.23
Dividend Payout % 0%11%12%13%9%17%11%8%6%4%6%6%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2014-20152015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)171.43%0.00%-5.26%105.56%-45.95%90.00%60.53%68.85%49.51%-48.05%16.25%
Change in YoY Net Profit Growth (%)0.00%-171.43%-5.26%110.82%-151.50%135.95%-29.47%8.33%-19.34%-97.57%64.30%

Sree Rayalaseema Hi-Strength Hypo Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:5%
5 Years:-2%
3 Years:-20%
TTM:-16%
Compounded Profit Growth
10 Years:21%
5 Years:20%
3 Years:-3%
TTM:20%
Stock Price CAGR
10 Years:28%
5 Years:30%
3 Years:-7%
1 Year:4%
Return on Equity
10 Years:14%
5 Years:16%
3 Years:14%
Last Year:11%

Last Updated: September 5, 2025, 1:36 pm

Balance Sheet

Last Updated: December 10, 2025, 3:27 am

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 15151515161717171717171717
Reserves 135157173222302308294371553734785905993
Borrowings 8887855578525772281651513
Other Liabilities 13099846064937659189174100121133
Total Liabilities 3673583573524604704455197879419071,0591,156
Fixed Assets 200194195182194194161134130105103112111
CWIP 0528003000000
Investments 32232343105651850164268253366407
Other Assets 135136137118161210262334494568551580638
Total Assets 3673583573524604704455197879419071,0591,156

Reserves and Borrowings Chart

Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + 2036154756099716013113288
Cash from Investing Activity + -9-5-3-19-27-24-38-115-1-99-8-40
Cash from Financing Activity + -9-32-12-1916-37-2210-52-20-22-8
Net Cash Flow 2-1-08-6-140-3571210339
Free Cash Flow 1214828-231591504613612385
CFO/OP 73%104%49%106%2%72%108%82%62%117%145%124%

Free Cash Flow

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow-55.00-46.00-41.00-5.00-32.0046.0045.0058.00121.00164.00106.0081.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 333354303846433938334559
Inventory Days 674237553434362762392449
Days Payable 97793966213824833221018
Cash Conversion Cycle 3-451195141555767505990
Working Capital Days -23-151121632242347456779
ROCE %11%13%14%9%9%14%15%21%26%26%16%15%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 62.09%62.09%62.09%61.84%61.84%61.84%61.84%61.84%61.84%61.84%61.84%61.84%
FIIs 0.59%0.60%0.64%0.65%0.57%0.55%0.14%0.08%0.14%0.12%0.06%0.06%
DIIs 0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.05%0.05%0.05%0.05%
Public 37.28%37.27%37.23%37.48%37.56%37.57%37.99%38.04%37.98%38.00%38.05%38.05%
No. of Shareholders 65,04547,18148,57648,53947,51046,56545,41145,95944,07843,53443,08542,527

Shareholding Pattern Chart

No. of Shareholders

Sree Rayalaseema Hi-Strength Hypo Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 10.0010.0010.0010.0010.00
Basic EPS (Rs.) 52.4746.0189.9759.8835.29
Diluted EPS (Rs.) 52.4746.0189.9759.8835.29
Cash EPS (Rs.) 55.2252.18101.1471.0864.77
Book Value[Excl.RevalReserv]/Share (Rs.) 534.98466.47437.58332.26226.03
Book Value[Incl.RevalReserv]/Share (Rs.) 534.98466.47437.58332.26226.03
Revenue From Operations / Share (Rs.) 371.59504.53961.34738.30530.63
PBDIT / Share (Rs.) 76.6277.32124.9792.8779.77
PBIT / Share (Rs.) 72.3571.14113.7081.6750.29
PBT / Share (Rs.) 69.4262.50110.9379.8047.10
Net Profit / Share (Rs.) 50.9646.0189.8759.8835.29
NP After MI And SOA / Share (Rs.) 52.4746.0189.8759.8835.29
PBDIT Margin (%) 20.6115.3212.9912.5715.03
PBIT Margin (%) 19.4714.1011.8211.069.47
PBT Margin (%) 18.6812.3811.5310.808.87
Net Profit Margin (%) 13.719.119.348.116.65
NP After MI And SOA Margin (%) 14.129.119.348.116.65
Return on Networth / Equity (%) 9.809.8620.5418.0215.61
Return on Capital Employeed (%) 12.3514.2025.5224.0521.55
Return On Assets (%) 8.428.6417.1813.0411.67
Long Term Debt / Equity (X) 0.000.010.000.000.00
Total Debt / Equity (X) 0.000.010.010.030.15
Asset Turnover Ratio (%) 0.640.951.961.941.89
Current Ratio (X) 8.999.754.172.352.65
Quick Ratio (X) 8.389.173.221.652.32
Inventory Turnover Ratio (X) 17.865.034.245.399.03
Dividend Payout Ratio (NP) (%) 5.718.693.895.017.08
Dividend Payout Ratio (CP) (%) 5.287.663.464.223.86
Earning Retention Ratio (%) 94.2991.3196.1194.9992.92
Cash Earning Retention Ratio (%) 94.7292.3496.5495.7896.14
Interest Coverage Ratio (X) 66.4633.3145.1649.6925.01
Interest Coverage Ratio (Post Tax) (X) 46.7523.5433.4833.0412.06
Enterprise Value (Cr.) 487.59518.25489.04718.64328.19
EV / Net Operating Revenue (X) 0.760.590.290.560.36
EV / EBITDA (X) 3.713.902.284.512.40
MarketCap / Net Operating Revenue (X) 1.330.970.420.640.44
Retention Ratios (%) 94.2891.3096.1094.9892.91
Price / BV (X) 0.921.050.941.431.05
Price / Net Operating Revenue (X) 1.330.970.420.640.44
EarningsYield 0.100.090.210.120.14

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Sree Rayalaseema Hi-Strength Hypo Ltd. is a Public Limited Listed company incorporated on 28/03/2005 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L24110AP2005PLC045726 and registration number is 045726. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 637.82 Cr. and Equity Capital is Rs. 17.16 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Chemicals - Inorganic - OthersGondiparla, Kurnool Andhra Pradesh 518004Contact not found
Management
NamePosition Held
Mr. T G Shilpa BharathChairperson & Managing Director
Mr. H Gurunath ReddyNon Executive Director
Mr. Satyam GadwalNon Executive Director
Mr. A KailashnathIndependent Director
Mr. Kamma Edlapalli KrishnaIndependent Director
Mrs. R TriveniIndependent Woman Director

FAQ

What is the intrinsic value of Sree Rayalaseema Hi-Strength Hypo Ltd and is it undervalued?

As of 27 April 2026, Sree Rayalaseema Hi-Strength Hypo Ltd's intrinsic value is ₹587.08, which is 22.05% higher than the current market price of ₹481.00, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (11.0 %), book value (₹588), dividend yield (0.62 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Sree Rayalaseema Hi-Strength Hypo Ltd?

Sree Rayalaseema Hi-Strength Hypo Ltd is trading at ₹481.00 as of 27 April 2026, with a FY2026-2027 high of ₹717 and low of ₹381. The stock is currently in the middle of its 52-week range. Market cap stands at ₹826 Cr..

How does Sree Rayalaseema Hi-Strength Hypo Ltd's P/E ratio compare to its industry?

Sree Rayalaseema Hi-Strength Hypo Ltd has a P/E ratio of 8.02, which is below the industry average of 90.58. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Sree Rayalaseema Hi-Strength Hypo Ltd financially healthy?

Key indicators for Sree Rayalaseema Hi-Strength Hypo Ltd: ROCE of 14.9 % is moderate. Dividend yield is 0.62 %.

Is Sree Rayalaseema Hi-Strength Hypo Ltd profitable and how is the profit trend?

Sree Rayalaseema Hi-Strength Hypo Ltd reported a net profit of ₹93 Cr in Mar 2025 on revenue of ₹638 Cr. Compared to ₹103 Cr in Mar 2022, the net profit shows a declining trend.

Does Sree Rayalaseema Hi-Strength Hypo Ltd pay dividends?

Sree Rayalaseema Hi-Strength Hypo Ltd has a dividend yield of 0.62 % at the current price of ₹481.00. The company pays dividends, though the yield is modest.

Last Updated: April 26, 2026, 12:13 am
Author: Getaka|Social: XLinkedIn
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Sree Rayalaseema Hi-Strength Hypo Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE